Simplex Trading, LLC Galmed Pharmaceuticals Ltd. Transaction History

Simplex Trading, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	BUY	$0.44 - $1.77 $707 - $2,846	1,608 Added 140.81%	2,750 $1,000
Q1 2022 May 02, 2022	SELL	$1.23 - $2.07 $3,466 - $5,833	-2,818 Reduced 71.16%	1,142 $1,000
Q4 2021 Feb 23, 2022	SELL	$1.75 - $3.03 $14,302 - $24,764	-8,173 Reduced 67.36%	3,960 $7,000
Q3 2021 Oct 28, 2021	BUY	$2.41 - $3.33 $156 - $216	65 Added 0.54%	12,133 $39,000
Q2 2021 Aug 12, 2021	BUY	$2.24 - $3.9 $27,032 - $47,065	12,068 New	12,068 $36,000
Q3 2019 Oct 15, 2019	SELL	$4.62 - $7.11 $221 - $341	-48 Closed	0 $0
Q2 2019 Jul 26, 2019	SELL	$5.68 - $8.68 $1,999 - $3,055	-352 Reduced 88.0%	48 $0
Q1 2019 Apr 18, 2019	BUY	$7.27 - $9.07 $2,908 - $3,628	400 New	400 $0

Ticker GLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,088,400
Market Cap $153M
Description
Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or t...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.